EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Capturing and reporting topical treatment use in childhood eczema: lessons for data collection in eczema trials

Katherine E Memory iD, Stephanie J MacNeill, Kim S Thomas iD, Miriam Santer, Matthew J Ridd

Clinical and Experimental Dermatology · 2025

DOI: 10.1093/ced/llae328 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Katherine E Memory und 4 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences Institute, Bristol Medical School, University of Bristol, Bristol, UK. Hauptthemen laut MEDLINE: Emollients, Eczema, Data Collection, Adrenal Cortex Hormones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emollients and topical corticosteroids (TCS) prevent and treat flares in eczema. However, topical treatment use is poorly recorded and reported in clinical trials. There is no clear consensus of how best to capture and summarize topical treatment use.

Objectives

To explore different ways of capturing and reporting topical treatment use in childhood eczema.

Methods

This was a secondary data analysis using 450 participants from the Best Emollients for Eczema (BEE) trial. Participants were allocated to use one type of emollient (lotion, cream, gel or ointment) ‘twice daily and when required’ for 16 weeks. Otherwise, clinical management remained unchanged. Parents completed weekly questions about topical therapy use and eczema symptoms. Two versions of topical treatment use questionnaires were used. The first (n = 202, 44.9%) asked parents to report treatment use on days 1–7, starting completion on the day they were randomized. The second (n = 248, 55.1%) reported use by day of the week (Monday to Sunday), starting completion the first Monday after randomization. Both underwent patient and public involvement review but the second version was tested more thoroughly using cognitive interviewing techniques, following parent feedback that questions on the first version were confusing. Descriptive statistics compared questionnaire completion and differences in emollient and TCS use.

Results

Overall, questionnaire completion for both emollient and TCS use decreased with time, but at weeks 1 and 16, it was 84.7% (381/450) and 58.9% (265/450) for emollient use, and 94.2% (424/450) and 80.4% (362/450) for TCS use, respectively. Fewer emollient use questionnaires were completed with the first (33.5%, 1082/3232 patient-weeks) than the second (87.9%, 3489/3968 patient-weeks) version (P < 0.001). TCS use questionnaire completion were similar for both (84.9%, 2744/3232 patient-weeks and 87.4%, 3468/3968 patient-weeks, P = 0.002). We present different ways of summarizing topical treatment use.

Conclusions

Although questionnaire completion was similar for TCS use, emollient-use data completeness was higher in the second version. When designing questionnaires, balancing the detail and complexity of questions is important, especially if being collected as a secondary outcome measure. Numerous ways of summarizing the same data can provide different information. Future collection and reporting of treatment use should reflect specific trial aims.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EmollientsEczemaData CollectionAdrenal Cortex HormonesDermatologic AgentsHumansChildMaleFemaleSurveys and QuestionnairesChild, PreschoolAdministration, TopicalAdministration, CutaneousInfantParents

Substanzen

EmollientsAdrenal Cortex HormonesDermatologic Agents

Autor:innen und Institutionen

  • Population Health Sciences Institute, Bristol Medical School, University of Bristol, Bristol, UK.
  • Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK.
  • Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
  • Primary Care & Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

ORCID-Profile: Katherine E Memory, Kim S Thomas

Förderung

  • NIHR

Zitieren

APA

Memory, K. E., MacNeill, S. J., Thomas, K. S., Santer, M., & Ridd, M. J. (2025). Capturing and reporting topical treatment use in childhood eczema: lessons for data collection in eczema trials. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae328

Vancouver

Memory KE, MacNeill SJ, Thomas KS, Santer M, Ridd MJ. Capturing and reporting topical treatment use in childhood eczema: lessons for data collection in eczema trials. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llae328

BibTeX
@article{Memory2025,
  author = {Memory, Katherine E and MacNeill, Stephanie J and Thomas, Kim S and Santer, Miriam and Ridd, Matthew J},
  title = {Capturing and reporting topical treatment use in childhood eczema: lessons for data collection in eczema trials},
  journal = {Clinical and Experimental Dermatology},
  year = {2025},
  doi = {10.1093/ced/llae328}
}
Kostenlos starten →